Advanced search×

Topical PRK 124 (0.125%) lotion for improving the signs and symptoms of rosacea.

Arisa A Ortiz, Laila L Elkeeb, Anne A Truitt, Rasha R Hindiyeh, Lisa L Aquino, Minh M Tran, and Gerald G Weinstein

J Drugs Dermatol 8(5):459-62 (2009) PMID 19537369

Current treatments for acne rosacea are often associated with unsatisfactory outcomes and adverse effects.

Version: za2963e q8zac q8zb4 q8zc5 q8zda q8zeb q8zfe q8zg9

Similar articles you may find interesting…

  1. Differential diagnosis of a red face.
    A H AH Murray

    J Cutan Med Surg (1998) PMID 9873123

  2. Flash lamp pumped dye laser for rosacea-associated telangiectasia and erythema.
    N J NJ Lowe, K L KL Behr, ... J J Ruiz-Esparza

    J Dermatol Surg Oncol 17(6):522-5 (1991) PMID 1828257

    The persistence of facial telangiectasis and erythema in patients with rosacea frequently presents a major cosmetic problem. It may also contribute to relapses of papular and pustular lesions. This study of 27 patients treated for their telangiectasia and erythema with a flash lamp pumped dye laser...
  3. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
    Uwe U Wollina

    Am J Clin Dermatol 8(3):157-73 (2007) PMID 17492844

    The topical calcineurin inhibitors (TCIs) pimecrolimus and tacrolimus are approved for atopic dermatitis but have additional potential in other inflammatory skin diseases. This article reviews their clinical use in non-atopic dermatitis diseases. In seborrheic dermatitis, asteatotic eczema, and cont...